Related Experiment Video

Updated: Aug 17, 2026

A Novel Method: Super-selective Adrenal Venous Sampling
06:08

A Novel Method: Super-selective Adrenal Venous Sampling

Published on: September 15, 2017

Hypertension in patients with Cushing's disease: pathophysiology, diagnosis, and management

Alan Sacerdote1, Karolina Weiss, Tri Tran

  • 1Department of Medicine, S.U.N.Y. Health Science Center at Brooklyn, 450 Clarkson Avenue, Brooklyn, NY 11203, USA.

Current Hypertension Reports
|May 26, 2005
PubMed

Insights

Hypertension is common in Cushing's syndrome due to multiple factors. New therapeutic strategies, including PPAR-gamma agonists, are needed to manage this condition effectively.

Area of Science:

  • Endocrinology
  • Cardiovascular Medicine
  • Internal Medicine

Background:

  • Hypertension is a frequent comorbidity in Cushing's disease/syndrome.
  • Pathophysiology involves mineralocorticoid and glucocorticoid receptor stimulation, insulin resistance, sleep apnea, and renin-angiotensin system overexpression.

Purpose of the Study:

  • To review the pathophysiology of hypertension in Cushing's disease.
  • To highlight current and emerging therapeutic options for Cushing's-specific hypertension.

Main Methods:

  • Literature review focusing on the mechanisms of hypertension in Cushing's syndrome.
  • Analysis of therapeutic strategies, including novel agents.

Main Results:

  • Cushing's disease significantly contributes to hypertension through complex mechanisms.
  • While treatment of Cushing's disease can improve hypertension, complete resolution is not always achieved.
  • Peroxisome proliferator-activated receptor (PPAR)-gamma agonists show promise in managing this patient population.

Conclusions:

  • Effective management of hypertension in Cushing's disease is crucial for reducing morbidity and mortality.
  • Novel therapeutic approaches, such as PPAR-gamma agonists, warrant further investigation for Cushing's-specific hypertension.

Related Concept Videos

Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
Cushing Syndrome I: Introduction01:26

Cushing Syndrome I: Introduction

Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...